Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody lateral flow assay for antibody prevalence studies following vaccination: a diagnostic accuracy study (2021)
Attributed to:
Centre for Global Infectious Disease Analysis, Imperial College London (GIDA) - COVID-19
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.12688/wellcomeopenres.17231.1
Publication URI: http://dx.doi.org/10.12688/wellcomeopenres.17231.1
Type: Journal Article/Review
Parent Publication: Wellcome Open Research